Dr. Philip Mease, MD – Seattle, WA

  • Safety of Ixekizumab in Patients with Psoriatic Arthritis: Results from a Pooled Analysis of Three Clinical Trials  

    Alice Gottlieb, Philip Mease, Arthritis Care & Research
  • Dual Inhibition of Tumour Necrosis Factor and Interleukin-17A with ABT-122: Open-Label Long-Term Extension Studies in Rheumatoid Arthritis or Psoriatic Arthritis  

    Philip Mease, MD, Rheumatology
  • Pain Mechanisms and Ultrasonic Inflammatory Activity as Prognostic Factors in Patients with Psoriatic Arthritis: A Prospective Cohort Study  

    Philip Mease, MD, Arthritis Care & Research
  • Join now to see all
  • You Might Also Like